Aurora Cannabis Inc. reported fiscal second-quarter 2026 revenue of $90.4 million, an 11% increase year-over-year, driven largely by record global medical marijuana sales.
The Edmonton-based company said medical cannabis net revenue rose 15% to $70.5 million, accounting for 78% of total revenue. International medical revenue grew 22% to $42.7 million, with strong performance in markets including Australia, Germany, Poland, and the United Kingdom. Aurora’s Canadian medical division also posted gains among both insured and self-paying patients.
Adjusted EBITDA climbed 52% to $15.4 million, while adjusted gross profit rose 22% to $51.8 million. The company ended the quarter with $141.9 million in cash and reported a debt-free cannabis business, excluding non-recourse debt associated with Bevo Farms Ltd.
“Our record results affirm the strength of our medical strategy,” said Executive Chairman and CEO Miguel Martin. “Aurora’s leadership in Canada and across key international markets reflects our disciplined approach, world-class production, and regulatory expertise.”
Consumer cannabis sales declined 34% to $6.9 million as the company continued to prioritize higher-margin medical operations. The plant propagation segment, operated under Bevo Farms, generated $11.6 million in revenue, up 34% from the same quarter last year.
Adjusted net income reached $7.1 million, more than double the $3 million reported in the prior-year period. Despite the improved operational performance, Aurora reported a net loss of $53.2 million from continuing operations, compared to a $1.4 million profit a year earlier, due in part to non-cash impairment charges and higher operating expenses.
Looking ahead to fiscal Q3 2026, Aurora expects continued year-over-year revenue growth, led by an 8% to 12% increase in global medical cannabis sales. The company also anticipates positive free cash flow and sustained strong gross margins supported by its medical-focused portfolio.
Aurora Cannabis trades on the NASDAQ and TSX under the ticker ACB.
More articles from The Marijuana Herald can be found below.
